Q3 2025 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2025-11-14 · accession 0001420506-25-003275
$109.6M
Reported value
7
Positions
2025-09-30
Period end
The Brief · Blue Water Life Science Advisors, LP · Q3 2025
AI · grounded in 13F
Blue Water Life Science Advisors, LP established a new position in ADPT valued at $32.1M. The fund also initiated new stakes in GH for $25.3M and NTRA for $22.8M. Additional new positions include PSNL, CDNA, and TEM.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES | $32.1M | 29.3% | 2,145,145 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $25.3M | 23.1% | 405,647 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $22.8M | 20.8% | 141,494 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $10.9M | 9.97% | 1,676,300 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $7.4M | 6.77% | 510,000 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $5.8M | 5.33% | 72,412 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $5.2M | 4.74% | 957,747 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.